HighTower Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.15M | Sell |
17,841
-4,548
| -20% | -$321K | ﹤0.01% | 2088 |
|
|
2025
Q4 | $1.51M | Sell |
22,389
-3,749
| -14% | -$252K | ﹤0.01% | 1840 |
|
|
2025
Q3 | $1.92M | Buy |
26,138
+8,007
| +44% | +$532K | ﹤0.01% | 1659 |
|
|
2025
Q2 | $943K | Sell |
18,131
-6,263
| -26% | -$356K | ﹤0.01% | 2051 |
|
|
2025
Q1 | $1.56M | Buy |
24,394
+7,800
| +47% | +$453K | ﹤0.01% | 1662 |
|
|
2024
Q4 | $793K | Sell |
16,594
-19,580
| -54% | -$1M | ﹤0.01% | 2134 |
|
|
2024
Q3 | $2.08M | Buy |
36,174
+6,075
| +20% | +$348K | ﹤0.01% | 1503 |
|
|
2024
Q2 | $1.58M | Buy |
30,099
+5,000
| +20% | +$219K | ﹤0.01% | 1577 |
|
|
2024
Q1 | $1.01M | Sell |
25,099
-8,522
| -25% | -$319K | ﹤0.01% | 1796 |
|
|
2023
Q4 | $1.24M | Buy |
33,621
+14,633
| +77% | +$551K | ﹤0.01% | 1732 |
|
|
2023
Q3 | $725K | Buy |
18,988
+583
| +3% | +$23.9K | ﹤0.01% | 1976 |
|
|
2023
Q2 | $668K | Buy |
18,405
+563
| +3% | +$19.2K | ﹤0.01% | 2008 |
|
|
2023
Q1 | $680K | Sell |
17,842
-72,510
| -80% | -$3.4M | ﹤0.01% | 1905 |
|
|
2022
Q4 | $5.14M | Sell |
90,352
-5,953
| -6% | -$305K | 0.01% | 841 |
|
|
2022
Q3 | $3.82M | Buy |
96,305
+80,941
| +527% | +$3.58M | 0.01% | 915 |
|
|
2022
Q2 | $674K | Buy |
15,364
+3,412
| +29% | +$148K | ﹤0.01% | 1873 |
|
|
2022
Q1 | $477K | Buy |
11,952
+812
| +7% | +$28.9K | ﹤0.01% | 2204 |
|
|
2021
Q4 | $446K | Buy |
11,140
+1,505
| +16% | +$56.2K | ﹤0.01% | 2232 |
|
|
2021
Q3 | $391K | Sell |
9,635
-519
| -5% | -$21.7K | ﹤0.01% | 2231 |
|
|
2021
Q2 | $461K | Buy |
10,154
+896
| +10% | +$39.7K | ﹤0.01% | 2096 |
|
|
2021
Q1 | $387K | Buy |
9,258
+2,710
| +41% | +$124K | ﹤0.01% | 2135 |
|
|
2020
Q4 | $281K | Buy |
+6,548
| New | +$235K | ﹤0.01% | 1983 |
|
|
2019
Q4 | – | Sell |
-28,629
| Closed | -$443K | – | 2451 |
|
|
2019
Q3 | $443K | Sell |
28,629
-500
| -2% | -$8.24K | ﹤0.01% | 1580 |
|
|
2019
Q2 | $500K | Sell |
29,129
-500
| -2% | -$8.07K | ﹤0.01% | 1513 |
|
|
2019
Q1 | $476K | Buy |
29,629
+1,014
| +4% | +$16.4K | ﹤0.01% | 1481 |
|
|
2018
Q4 | $418K | Buy |
28,615
+1,559
| +6% | +$24.9K | ﹤0.01% | 1448 |
|
|
2018
Q3 | $492K | Buy |
27,056
+5,707
| +27% | +$100K | ﹤0.01% | 1467 |
|
|
2018
Q2 | $359K | Sell |
21,349
-5,519
| -21% | -$104K | ﹤0.01% | 1602 |
|
|
2018
Q1 | $527K | Buy |
26,868
+9,320
| +53% | +$180K | ﹤0.01% | 1392 |
|
|
2017
Q4 | $356K | Sell |
17,548
-5,882
| -25% | -$108K | ﹤0.01% | 1615 |
|
|
2017
Q3 | $407K | Sell |
23,430
-11,419
| -33% | -$155K | ﹤0.01% | 1537 |
|
|
2017
Q2 | $446K | Buy |
34,849
+7,499
| +27% | +$100K | ﹤0.01% | 1427 |
|
|
2017
Q1 | $354K | Sell |
27,350
-12,200
| -31% | -$154K | ﹤0.01% | 1474 |
|
|
2016
Q4 | $392K | Buy |
39,550
+500
| +1% | +$5.48K | ﹤0.01% | 1356 |
|
|
2016
Q3 | $473K | Hold |
39,050
| – | – | 0.01% | 1267 |
|
|
2016
Q2 | $336K | Buy |
39,050
+5,414
| +16% | +$53.4K | ﹤0.01% | 1280 |
|
|
2016
Q1 | $319K | Buy |
33,636
+6,400
| +23% | +$60.2K | ﹤0.01% | 1583 |
|
|
2015
Q4 | $470K | Sell |
27,236
-277
| -1% | -$4.42K | 0.01% | 1347 |
|
|
2015
Q3 | $369K | Buy |
27,513
+9,625
| +54% | +$193K | ﹤0.01% | 1353 |
|
|
2015
Q2 | $404K | Sell |
17,888
-11,787
| -40% | -$207K | 0.01% | 1089 |
|
|
2015
Q1 | $424K | Sell |
29,675
-8,100
| -21% | -$117K | 0.01% | 1121 |
|
|
2014
Q4 | $365K | Buy |
37,775
+8,500
| +29% | +$75.5K | 0.01% | 1153 |
|
|
2014
Q3 | $266K | Hold |
29,275
| – | – | ﹤0.01% | 1257 |
|
|
2014
Q2 | $289K | Hold |
29,275
| – | – | 0.01% | 1268 |
|
|
2014
Q1 | $372K | Sell |
29,275
-1,000
| -3% | -$14.8K | 0.01% | 1093 |
|
|
2013
Q4 | $454K | Buy |
30,275
+500
| +2% | +$6.43K | 0.01% | 1002 |
|
|
2013
Q3 | $329K | Sell |
29,775
-2,000
| -6% | -$16.7K | 0.01% | 997 |
|
|
2013
Q2 | $253K | Buy |
+31,775
| New | +$202K | 0.01% | 1050 |
|
Other funds holding HALO
VCM
VPM
HighTower Advisors's HALO Position: Q1 2026 in Review
HighTower Advisors reduced its Halozyme (HALO) stake by 20% in Q1 2026, selling an estimated $321K and leaving 17,841 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2088.
HighTower Advisors first reported a position in HALO in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.14M in Q4 2022. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- HighTower Advisors held 17,841 shares of Halozyme worth $1.15M as of Q1 2026.
- HighTower Advisors sold 4,548 Halozyme shares in Q1 2026, an estimated $321K.
- Halozyme made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2088 holding.
- HighTower Advisors first reported a position in Halozyme in Q2 2013 and has held it in 48 quarters since.
- HighTower Advisors's Halozyme position peaked at $5.14M in Q4 2022.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.